Riskpilot← Back to searchSign inGet full accessLEGE RENGIFO AS
ASActiveOrg 919927240Trelastgata 27, 0191 OsloGeneral medical practice activities · NACE 8621Est. 20171 employees
Revenue 2024
NOK 3M
+570% vs 2023
EBITDA margin
13.0%
+81% vs 2023
Equity ratio
48.2%
Financial strength
Net profit 2024
NOK 308K
+81% vs 2023
| Revenue | NOK 3M | +570% |
| EBITDA | NOK 396K | +81% |
| Net profit | NOK 308K | +81% |
| Total assets | NOK 1M | +237% |
| Equity | NOK 484K | +176% |
| Employees | 1 | — |
Legal name
LEGE RENGIFO AS
Org number
919927240
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. november 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Tilrettelegge elektiv medisinsk behandling i utlandet. Vi ønsker å formidle medisinske og kirurgiske prosedyer i utlandet. Kunder/pasienter kan velge å konsultere gjennom nett, telefon og andre medier for å kartlegge behandlingsalternativer. Etter kundens eget ønske kan selskapet tilby administrative tjenester, slik som reservasjon av hotell og flyreiser. Legepraksis på legekontor og legevakt.
Address
Trelastgata 27, 0191 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 626 | 0 | 0 | 455 | 3 049 |
| Staff expenses | −240 | −64 | −0 | −0 | −1 779 |
| EBITDA | 577 | −350 | −25 | 218 | 396 |
| Depreciation & amort. | −0 | −38 | −0 | −0 | −0 |
| EBIT | 577 | −388 | −25 | 218 | 396 |
| Net financials | 0 | 0 | 0 | 0 | −1 |
| Profit before tax | 577 | −388 | −25 | 219 | 395 |
| Tax | 119 | −0 | −0 | 48 | 87 |
| Net profit | 457 | −388 | −25 | 170 | 308 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 623 | 243 | 0 | 298 | 1 005 |
| Equity | 30 | 128 | 0 | 176 | 484 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 593 | 115 | 0 | 123 | 521 |
| Total debt | 593 | 115 | 0 | 123 | 521 |
EBITDA margin
13.0%
This company
15.8%
Market median
-18% vs market
20202024
Equity ratio
48.2%
This company
38.2%
Market median
+26% vs market
20202024
Return on equity
63.7%
This company
18.4%
Market median
+246% vs market
20202024
Net profit margin
10.1%
This company
8.1%
Market median
+25% vs market
20202024
Asset turnover
3.03×
This company
1.12×
Market median
+171% vs market
20202024
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rengifo Holding As
LEGE RENGIFO AS Board members of LEGE RENGIFO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jorge Alexis Rengifo Pereda | Chairman | 0 companies |